|
Market Closed -
Japan Exchange
02:30:00 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 6,471.00 JPY | +2.60% |
|
+1.94% | +33.84% |
| 07:52am | Takeda Pharmaceutical Company Limited, Q2 2027 Earnings Call, Oct 29, 2026 | |
| 06:28am | Takeda Pharmaceutical Posts Higher H1 Attributable Net Profit; Revenue Up | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 63.65B | |||||
| 1,148B | |||||
| 652B | |||||
| 505B | |||||
| 384B | |||||
| 348B |
Select your edition
All financial news and data tailored to specific country editions
